Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying
Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying
內部人士正在買入Dominari Holdings和其他2只低於3美元的股票
The Dow Jones index closed lower by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週三收盤下跌400多點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
Dominari Holdings
多米納裏控股
- The Trade: Dominari Holdings Inc (NASDAQ:DOMH) President Kyle Michael Wool acquired a total of 8,500 shares an average price of $2.99. To acquire these shares, it cost around $25,390.
- What's Happening: On April 1, Dominari Holdings posted a narrower quarterly loss.
- What Dominari Holdings Does: Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development.
- 交易：多明納裏控股公司（納斯達克股票代碼：DOMH）總裁凱爾·邁克爾·伍爾 共收購了8,500股股票 平均價格爲2.99美元。收購這些股票的成本約爲25,390美元。
- 發生了什麼：4月1日，多明納裏控股公佈的季度虧損有所收窄。
- Dominari Holdings的所作所爲：Dominari Holdings Inc是一家生物技術公司，正在開發多元化的小分子抗癌和抗病毒療法產品組合。
BioRestorative Therapies
生物修復療法
- The Trade: BioRestorative Therapies Inc (NASDAQ:BRTX) Director, VP of Research and Development Francisco Silva acquired a total of 8,308 shares at at an average price of $1.23. To acquire these shares, it cost around $10,229.
- What's Happening: On April 8, BioRestorative Therapies partnered with Galen Patient Recruitment to accelerate completion of enrollment in Phase 2 trial of BRTX-100 in chronic lumbar disc disease.
- What BioRestorative Therapies Does: BioRestorative Therapies Inc is a biotechnology company based in the United States.
- 貿易：生物修復療法公司（納斯達克股票代碼：BRTX）董事、研發副總裁弗朗西斯科·席爾瓦 共收購了8,308股股票 平均價格爲1.23美元。收購這些股票的成本約爲10,229美元。
- 發生了什麼：4月8日，BioRestorative Therapies與Galen Patient Recruitment合作，加速完成慢性腰椎間盤疾病 BRTX-100 二期試驗的註冊工作。
- 生物修復療法的作用：生物修復療法公司是一家總部位於美國的生物技術公司。
Lion Copper and Gold
獅子銅和金
- The Trade: Lion Copper and Gold Corp (OTC:LCGMF) Director Tony L Alford acquired a total of 5,072,683 shares at an average price of $0.06. The insider spent around $309,296 to buy those shares.
- What's Happening: The company's stock gained around 6% over the past month.
- What Lion Copper and Gold Does: Lion Copper and Gold Corp is a Canadian mineral exploration company that is engaged in the acquisition, exploration, and development of copper projects in Nevada, Alaska, and Montana in the United States and British Columbia, Canada.
- 貿易：Lion Copper and Gold Corp（場外交易代碼：LCGMF）董事託尼·奧爾福德 共收購了5,072,683股股票 平均價格爲0.06美元。知情人士花費了約309,296美元購買了這些股票。
- 發生了什麼：該公司的股票在過去一個月中上漲了約6％。
- Lion Copper and Gold 做什麼：Lion Copper and Gold Corp 是一家加拿大礦產勘探公司，在美國內華達州、阿拉斯加州和蒙大拿州以及加拿大不列顛哥倫比亞省從事銅項目的收購、勘探和開發。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道